PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

State-Specific Prevalence of Tobacco Product Use Among Adults - United States, 2014-2015.

Abstract Despite recent declines in cigarette smoking prevalence, the tobacco product landscape has shifted to include emerging tobacco products* (1,2). Previous research has documented adult use of smokeless tobacco and cigarettes by state (3); however, state-specific data on other tobacco products are limited. To assess tobacco product use in the 50 U.S. states and the District of Columbia (DC), CDC and the National Cancer Institute analyzed self-reported use of six tobacco product types: cigarettes, cigars, regular pipes, water pipes, electronic cigarettes (e-cigarettes), and smokeless tobacco products among adults aged ≥18 years using data from the 2014-2015 Tobacco Use Supplement to the Current Population Survey (TUS-CPS). Prevalence of ever-use of any tobacco product ranged from 27.0% (Utah) to 55.4% (Wyoming). Current (every day or some days) use of any tobacco product ranged from 10.2% (California) to 27.7% (Wyoming). Cigarettes were the most common currently used tobacco product in all states and DC. Among current cigarette smokers, the proportion who currently used one or more other tobacco products ranged from 11.5% (Delaware) to 32.3% (Oregon). Differences in tobacco product use across states underscore the importance of implementing proven population-level strategies to reduce tobacco use and expanding these strategies to cover all forms of tobacco marketed in the United States. Such strategies could include comprehensive smoke-free policies, tobacco product price increases, anti-tobacco mass media campaigns, and barrier-free access to clinical smoking cessation resources (1,4).
PMID
Related Publications

Tobacco Use Among Working Adults - United States, 2014-2016.

Multiple tobacco product use among adults in the United States: cigarettes, cigars, electronic cigarettes, hookah, smokeless tobacco, and snus.

Tobacco product use among adults--United States, 2012-2013.

Tobacco Product Use Among Adults - United States, 2013-2014.

Tobacco Product Use Among Adults - United States, 2015.

Authors

Mayor MeshTerms
Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 29370150
OWN - NLM
STAT- MEDLINE
DCOM- 20180126
LR  - 20180126
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 67
IP  - 3
DP  - 2018 Jan 26
TI  - State-Specific Prevalence of Tobacco Product Use Among Adults - United States,
      2014-2015.
PG  - 97-102
LID - 10.15585/mmwr.mm6703a3 [doi]
AB  - Despite recent declines in cigarette smoking prevalence, the tobacco product
      landscape has shifted to include emerging tobacco products* (1,2). Previous
      research has documented adult use of smokeless tobacco and cigarettes by state
      (3); however, state-specific data on other tobacco products are limited. To
      assess tobacco product use in the 50 U.S. states and the District of Columbia
      (DC), CDC and the National Cancer Institute analyzed self-reported use of six
      tobacco product types: cigarettes, cigars, regular pipes, water pipes, electronic
      cigarettes (e-cigarettes), and smokeless tobacco products among adults aged >/=18
      years using data from the 2014-2015 Tobacco Use Supplement to the Current
      Population Survey (TUS-CPS). Prevalence of ever-use of any tobacco product ranged
      from 27.0% (Utah) to 55.4% (Wyoming). Current (every day or some days) use of any
      tobacco product ranged from 10.2% (California) to 27.7% (Wyoming). Cigarettes
      were the most common currently used tobacco product in all states and DC. Among
      current cigarette smokers, the proportion who currently used one or more other
      tobacco products ranged from 11.5% (Delaware) to 32.3% (Oregon). Differences in
      tobacco product use across states underscore the importance of implementing
      proven population-level strategies to reduce tobacco use and expanding these
      strategies to cover all forms of tobacco marketed in the United States. Such
      strategies could include comprehensive smoke-free policies, tobacco product price
      increases, anti-tobacco mass media campaigns, and barrier-free access to clinical
      smoking cessation resources (1,4).
FAU - Odani, Satomi
AU  - Odani S
FAU - Armour, Brian S
AU  - Armour BS
FAU - Graffunder, Corinne M
AU  - Graffunder CM
FAU - Willis, Gordon
AU  - Willis G
FAU - Hartman, Anne M
AU  - Hartman AM
FAU - Agaku, Israel T
AU  - Agaku IT
LA  - eng
PT  - Journal Article
DEP - 20180126
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
SB  - IM
MH  - Adult
MH  - Health Surveys
MH  - Humans
MH  - Prevalence
MH  - Tobacco Products/*utilization
MH  - Tobacco Use Disorder/*epidemiology
MH  - United States/epidemiology
COIS- No conflicts of interest were reported.
EDAT- 2018/01/26 06:00
MHDA- 2018/01/27 06:00
CRDT- 2018/01/26 06:00
PHST- 2018/01/26 06:00 [entrez]
PHST- 2018/01/26 06:00 [pubmed]
PHST- 2018/01/27 06:00 [medline]
AID - 10.15585/mmwr.mm6703a3 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):97-102. doi: 10.15585/mmwr.mm6703a3.